Product
Autologous Bone Marrow-Derived Mesenchymal Stem Cell
1 clinical trial
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type 2 DiabetesStatus: Completed, Estimated PCD: 2019-08-01